share_log

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $15 Price Target

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $15 Price Target

JMP證券重申OptimizerX的市場跑贏大盤,維持15美元的目標股價
Moomoo 24/7 ·  04/16 11:18

JMP Securities analyst Constantine Davides reiterates OptimizeRx (NASDAQ:OPRX) with a Market Outperform and maintains $15 price target.

JMP Securities分析師康斯坦丁·戴維斯重申OptimizerX(納斯達克股票代碼:OPRX)的市場跑贏大盤,並維持15美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論